185 related articles for article (PubMed ID: 11992648)
1. Modulation of mdr1a and CYP3A gene expression in the intestine and liver as possible cause of changes in the cyclosporin A disposition kinetics by dexamethasone.
Yokogawa K; Shimada T; Higashi Y; Itoh Y; Masue T; Ishizaki J; Asahi M; Miyamoto K
Biochem Pharmacol; 2002 Feb; 63(4):777-83. PubMed ID: 11992648
[TBL] [Abstract][Full Text] [Related]
2. Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasone.
Jin M; Shimada T; Yokogawa K; Nomura M; Kato Y; Tsuji A; Miyamoto K
Int J Pharm; 2006 Feb; 309(1-2):81-6. PubMed ID: 16384676
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
[TBL] [Abstract][Full Text] [Related]
4. Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats.
Perloff MD; von Moltke LL; Greenblatt DJ
Xenobiotica; 2004 Feb; 34(2):133-50. PubMed ID: 14985144
[TBL] [Abstract][Full Text] [Related]
5. Using real-time quantitative TaqMan RT-PCR to evaluate the role of dexamethasone in gene regulation of rat P-glycoproteins mdr1a/1b and cytochrome P450 3A1/2.
Mei Q; Richards K; Strong-Basalyga K; Fauty SE; Taylor A; Yamazaki M; Prueksaritanont T; Lin JH; Hochman J
J Pharm Sci; 2004 Oct; 93(10):2488-96. PubMed ID: 15349958
[TBL] [Abstract][Full Text] [Related]
6. Influence of cytarabine and cyclophosphamide on the disposition kinetics of cyclosporin A after bone marrow transplantation.
Shimada T; Aoki Y; Yokogawa K; Nomura M; Ishizaki J; Nishigami J; Miyamoto K
Transpl Int; 2003 Nov; 16(11):788-93. PubMed ID: 12844214
[TBL] [Abstract][Full Text] [Related]
7. Site-dependent contributions of P-glycoprotein and CYP3A to cyclosporin A absorption, and effect of dexamethasone in small intestine of mice.
Jin M; Shimada T; Yokogawa K; Nomura M; Ishizaki J; Piao Y; Kato Y; Tsuji A; Miyamoto K
Biochem Pharmacol; 2006 Oct; 72(8):1042-50. PubMed ID: 16939683
[TBL] [Abstract][Full Text] [Related]
8. Capsaicin pretreatment increased the bioavailability of cyclosporin in rats: involvement of P-glycoprotein and CYP 3A inhibition.
Zhai XJ; Shi F; Chen F; Lu YN
Food Chem Toxicol; 2013 Dec; 62():323-8. PubMed ID: 24013073
[TBL] [Abstract][Full Text] [Related]
9. Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-glycoprotein after high-dose steroid therapy.
Shimada T; Terada A; Yokogawa K; Kaneko H; Nomura M; Kaji K; Kaneko S; Kobayashi K; Miyamoto K
Transplantation; 2002 Nov; 74(10):1419-24. PubMed ID: 12451243
[TBL] [Abstract][Full Text] [Related]
10. Modulation of P-glycoprotein expression by cytochrome P450 3A inducers in male and female rat livers.
Salphati L; Benet LZ
Biochem Pharmacol; 1998 Feb; 55(4):387-95. PubMed ID: 9514072
[TBL] [Abstract][Full Text] [Related]
11. Effect of dexamethasone on the intestinal first-pass metabolism of indinavir in rats: evidence of cytochrome P-450 3A [correction of P-450 A] and p-glycoprotein induction .
Lin JH; Chiba M; Chen IW; Nishime JA; deLuna FA; Yamazaki M; Lin YJ
Drug Metab Dispos; 1999 Oct; 27(10):1187-93. PubMed ID: 10497146
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation by dexamethasone of fluvastatin-inducible CYP2B expression in primary cultures of rat hepatocytes: role of CYP3A.
Kocarek TA; Reddy AB
Biochem Pharmacol; 1998 May; 55(9):1435-43. PubMed ID: 10076536
[TBL] [Abstract][Full Text] [Related]
13. Long-term levothyroxine treatment decreases the oral bioavailability of cyclosporin A by inducing P-glycoprotein in small intestine.
Jin M; Shimada T; Shintani M; Yokogawa K; Nomura M; Miyamoto K
Drug Metab Pharmacokinet; 2005 Oct; 20(5):324-30. PubMed ID: 16272749
[TBL] [Abstract][Full Text] [Related]
14. Expression profiles of drug-metabolizing enzyme CYP3A and drug efflux transporter multidrug resistance 1 subfamily mRNAS in small intestine.
Takara K; Ohnishi N; Horibe S; Yokoyama T
Drug Metab Dispos; 2003 Oct; 31(10):1235-9. PubMed ID: 12975332
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of decrease of oral bioavailability of cyclosporin A during immunotherapy upon coadministration of amphotericin B.
Ishizaki J; Ito S; Jin M; Shimada T; Ishigaki T; Harasawa Y; Yokogawa K; Takami A; Nakao S; Miyamoto K
Biopharm Drug Dispos; 2008 May; 29(4):195-203. PubMed ID: 18240156
[TBL] [Abstract][Full Text] [Related]
16. Selective induction of cytochrome P450 3A1 by dexamethasone in cultured rat hepatocytes: analysis with a novel reverse transcriptase-polymerase chain reaction assay section sign.
Hoen PA; Commandeur JN; Vermeulen NP; Van Berkel TJ; Bijsterbosch MK
Biochem Pharmacol; 2000 Nov; 60(10):1509-18. PubMed ID: 11020454
[TBL] [Abstract][Full Text] [Related]
17. Phenobarbital and dexamethasone induce expression of cytochrome P-450 genes from subfamilies IIB, IIC, and IIIA in mouse liver.
Corcos L
Drug Metab Dispos; 1992; 20(6):797-801. PubMed ID: 1362929
[TBL] [Abstract][Full Text] [Related]
18. Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. II: establishment and evaluation of dexamethasone-pretreated female rats.
Kanazu T; Yamaguchi Y; Okamura N; Baba T; Koike M
Xenobiotica; 2004 May; 34(5):403-13. PubMed ID: 15370957
[TBL] [Abstract][Full Text] [Related]
19. Ethynylestradiol-mediated induction of hepatic CYP3A9 in female rats: implication for cyclosporine metabolism.
Jäger W; Correia MA; Bornheim LM; Mahnke A; Hanstein WG; Xue L; Benet LZ
Drug Metab Dispos; 1999 Dec; 27(12):1505-11. PubMed ID: 10570034
[TBL] [Abstract][Full Text] [Related]
20. Differential induction of midazolam metabolism in the small intestine and liver by oral and intravenous dexamethasone pretreatment in rat.
Eeckhoudt SL; Horsmans Y; Verbeeck RK
Xenobiotica; 2002 Nov; 32(11):975-84. PubMed ID: 12487727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
